3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Kidney Neoplasms
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
8
Zoledronic Acid
5
Therapeutics
5
Flow Cytometry
5
pembrolizumab
3
fludarabine
3
Specimen Handling
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Immunologic Techniques
3
Gemcitabine
3
Amplified Fragment Length Polymorphism Analysis
3
venetoclax
2
trametinib
2
ruxolitinib
2
pertuzumab
2
palbociclib
2
liposomal doxorubicin
2
liposomal amphotericin B
2
dabrafenib
2
copanlisib
2
aldesleukin
2
abiraterone
2
Vorinostat
2
Trastuzumab
2
Surveys and Questionnaires
2
Sunitinib
2
Sorafenib
2
Rituximab
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Interferons
×
Plasma cell
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled